These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36824724)

  • 1.
    D'Alessandro A; Nouraie SM; Zhang Y; Cendali F; Gamboni F; Reisz JA; Zhang X; Bartsch KW; Galbraith MD; Gordeuk VR; Gladwin MT
    bioRxiv; 2023 Feb; ():. PubMed ID: 36824724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction.
    D'Alessandro A; Nouraie SM; Zhang Y; Cendali F; Gamboni F; Reisz JA; Zhang X; Bartsch KW; Galbraith MD; Gordeuk VR; Gladwin MT
    Am J Hematol; 2023 Jul; 98(7):1017-1028. PubMed ID: 36971592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment.
    D'Alessandro A; Nouraie SM; Zhang Y; Cendali F; Gamboni F; Reisz JA; Zhang X; Bartsch KW; Galbraith MD; Espinosa JM; Gordeuk VR; Gladwin MT
    Haematologica; 2023 Dec; 108(12):3418-3432. PubMed ID: 37439373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients, as a function of therapeutic transfusion and hydroxyurea treatment.
    D'Alessandro A; Nouraie SM; Zhang Y; Cendali F; Gamboni F; Reisz JA; Zhang X; Bartsch KW; Galbraith MD; Espinosa JM; Gordeuk VR; Gladwin MT
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of red blood cell (RBC) transfusion on sickle cell disease recipient plasma and RBC metabolism.
    Culp-Hill R; Srinivasan AJ; Gehrke S; Kamyszek R; Ansari A; Shah N; Welsby I; D'Alessandro A
    Transfusion; 2018 Dec; 58(12):2797-2806. PubMed ID: 30265764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease.
    Schroeder P; Fulzele K; Forsyth S; Ribadeneira MD; Guichard S; Wilker E; Marshall CG; Drake A; Fessler R; Konstantinidis DG; Seu KG; Kalfa TA
    J Pharmacol Exp Ther; 2022 Mar; 380(3):210-219. PubMed ID: 35031585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events.
    Chadebech P; Bodivit G; Di Liberto G; Jouard A; Vasseur C; Pirenne F; Bartolucci P
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
    Hebert N; Rakotoson MG; Bodivit G; Audureau E; Bencheikh L; Kiger L; Oubaya N; Pakdaman S; Sakka M; Di Liberto G; Chadebech P; Vingert B; Pirenne F; Galactéros F; Cambot M; Bartolucci P
    Am J Hematol; 2020 Nov; 95(11):1235-1245. PubMed ID: 32681733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic assessment of red blood cell mediated microvascular occlusion.
    Man Y; Kucukal E; An R; Watson QD; Bosch J; Zimmerman PA; Little JA; Gurkan UA
    Lab Chip; 2020 Jun; 20(12):2086-2099. PubMed ID: 32427268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion support for patients with sickle cell disease.
    Wallace LR; Thibodeaux SR
    Transfus Apher Sci; 2022 Oct; 61(5):103556. PubMed ID: 36100552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of benefits from using fresh and cryopreserved blood to transfuse patients with acute sickle cell disease.
    Chadebech P; de Ménorval MA; Bodivit G; Mekontso-Dessap A; Pakdaman S; Jouard A; Galactéros F; Bierling P; Habibi A; Pirenne F
    Transfusion; 2016 Jul; 56(7):1730-8. PubMed ID: 27184475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
    Nader E; Romana M; Connes P
    Front Immunol; 2020; 11():454. PubMed ID: 32231672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities.
    Alramadhani D; Aljahdali AS; Abdulmalik O; Pierce BD; Safo MK
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dense red blood cell and oxygen desaturation in sickle-cell disease.
    Di Liberto G; Kiger L; Marden MC; Boyer L; Poitrine FC; Conti M; Rakotoson MG; Habibi A; Khorgami S; Vingert B; Maitre B; Galacteros F; Pirenne F; Bartolucci P
    Am J Hematol; 2016 Oct; 91(10):1008-13. PubMed ID: 27380930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle Cell Trait Increases Red Blood Cell Storage Hemolysis and Post-Transfusion Clearance in Mice.
    Osei-Hwedieh DO; Kanias T; Croix CS; Jessup M; Xiong Z; Sinchar D; Franks J; Xu Q; M Novelli E; Sertorio JT; Potoka K; Binder RJ; Basu S; Belanger AM; Kim-Shapiro DB; Triulzi D; Lee JS; Gladwin MT
    EBioMedicine; 2016 Sep; 11():239-248. PubMed ID: 27523807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-6-phosphate-dehydrogenase deficient red blood cell units are associated with decreased posttransfusion red blood cell survival in children with sickle cell disease.
    Sagiv E; Fasano RM; Luban NLC; Josephson CD; Stowell SR; Roback JD; Francis RO; Yee MEM
    Am J Hematol; 2018 May; 93(5):630-634. PubMed ID: 29377292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More efficient exchange of sickle red blood cells can be achieved by exchanging the densest red blood cells: An ex vivo proof of concept study.
    Thibodeaux SR; Tanhehco YC; Irwin L; Jamensky L; Schell K; O'Doherty U
    Transfus Apher Sci; 2019 Feb; 58(1):100-106. PubMed ID: 30616959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients.
    Conran N; Oresco-Santos C; Acosta HC; Fattori A; Saad ST; Costa FF
    Br J Haematol; 2004 Feb; 124(4):547-54. PubMed ID: 14984506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.